Julia Wang
Director of Finance/CFO at BEIGENE, LTD.
Net worth: 4 M $ as of 2024-03-30
Profile
Julia Wang is Chief Financial Officer of BeiGene Ltd. In the past Ms. Wang occupied the position of SVP-Global Business Finance & Corporate Planning at Alexion Pharmaceuticals, Inc. She received an MBA from The Fuqua School of Business and an undergraduate degree from Shandong Normal University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BEIGENE LTD
0.03% | 2024-02-28 | 325,247 ( 0.03% ) | 4 M $ | 2024-03-30 |
Julia Wang active positions
Companies | Position | Start |
---|---|---|
BEIGENE, LTD. | Director of Finance/CFO | 2021-06-29 |
Former positions of Julia Wang
Companies | Position | End |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2019-12-31 |
QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | 2017-12-31 |
Training of Julia Wang
Shandong Normal University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
QUEST DIAGNOSTICS INCORPORATED | Health Services |
BEIGENE, LTD. | Health Technology |
Private companies | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Julia Wang